Clinical trial
Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat…
NCT00217282 · Mt. Sinai Medical Center, Miami, Other · Completed
Key facts
| NCT number | NCT00217282 |
|---|---|
| Title | Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer |
| Official title | Phase II Trial OF Oxaliplatin and Gemcitabine With Bevacizumab in Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Mt. Sinai Medical Center, Miami, Other |
| Collaborators | Sanofi-Synthelabo Industry Genentech, Inc. |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | oxaliplatin, gemcitabine, bevacizumab |
| Enrollment | 45 |
| Start date | Jun 1, 2004 |
| Primary completion | Jun 1, 2007 |
| Completion | Mar 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | May 22, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: